- Nyhet
Molecular Biology of RGS Proteins
Del 86 i serien Progress in Molecular Biology and Translational Science
2 096 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Du är på sajten för privatpersoner.
Du är på sajten för privatpersoner.
Del 86 i serien Progress in Molecular Biology and Translational Science
2 096 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Dr. Fisher is a 1983 graduate of Iowa State University (Ph.D.), who performed post-doctoral research at the University of Texas Health Science Center, San Antonio, before joining the faculty in Pharmacology at the University of Iowa in 1987. He was promoted to associate professor in 1993 and to professor in 2004. He has a secondary appointment in the Department of Internal Medicine and is a member of the Molecular and Cellular Biology interdisciplinary graduate program, the Holden Cancer Center, the Medical Scientist Training Program, and the Gene Therapy Center. His research focuses on the biology and signaling of RGS proteins and G proteins. He has served on numerous NIH study sections and his funding includes an R01 to study novel actions of RGS6 in tumor suppression and DNA damage signaling.
Du är på sajten för privatpersoner.
Del 86 i serien Progress in Molecular Biology and Translational Science
2 096 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Dr. Fisher is a 1983 graduate of Iowa State University (Ph.D.), who performed post-doctoral research at the University of Texas Health Science Center, San Antonio, before joining the faculty in Pharmacology at the University of Iowa in 1987. He was promoted to associate professor in 1993 and to professor in 2004. He has a secondary appointment in the Department of Internal Medicine and is a member of the Molecular and Cellular Biology interdisciplinary graduate program, the Holden Cancer Center, the Medical Scientist Training Program, and the Gene Therapy Center. His research focuses on the biology and signaling of RGS proteins and G proteins. He has served on numerous NIH study sections and his funding includes an R01 to study novel actions of RGS6 in tumor suppression and DNA damage signaling.